CALL/TEVA PHARMACEUTICAL INDUSTRIES/22/1/21.06.24 Stock

Warrant

DE000GG5UAG9

Market Closed - Börse Stuttgart 04:12:56 2024-06-04 EDT
0.02 EUR +66.67% Intraday chart for CALL/TEVA PHARMACEUTICAL INDUSTRIES/22/1/21.06.24
1 month+66.67%
Date Price Change
24-06-04 0.02 +66.67%
24-06-03 0.012 -20.00%
24-05-31 0.015 0.00%
24-05-30 0.015 -25.00%
24-05-29 0.02 0.00%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 04:12 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer Goldman Sachs
WKN GG5UAG
ISINDE000GG5UAG9
Date issued 2024-03-25
Strike 22 $
Maturity 2024-06-21 (17 Days)
Parity 1 : 1
Emission price 0.01
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.06
Lowest since issue 0.004
Delta0.07x
Omega 14.51
Premium29.5x
Gearing195.95x
Moneyness 0.7752
Difference Strike 5.37 $
Difference Strike %+24.41%
Spread 0.1
Spread %76.92%
Theoretical value 0.0350
Implied Volatility 63.42 %
Total Loss Probability 96.98 %
Intrinsic value 0.000000
Present value 0.0350
Break even 22.04 €
Theta-0.03x
Vega0x
Rho0x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.63 USD
Average target price
17.71 USD
Spread / Average Target
+6.47%
Consensus